Анджела Маас - Женское сердце. Современный подход к здоровью женщин

Wenger N. K., Ferdinand K. C., Bairey Merz C. N. et al. Women, hypertension, and the systolic blood pressure intervention trial // Am J Med, 2016. — № 29. — P. 1030–1036.

Drost J. T., Arpaci G., Ottervanger J. P. et al. Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk EValuation in FEMales study (PREVFEM) // Eur J Prev Cardiol, 2012. — № 19 (5). — P. 1138–1144.

Basit S., Wohlfart J., Boyd H. A. Pre-eclampsia and risk of dementia later in life: nationwide cohort study // BMJ, 2018. — № 363. — K4109.

Drost J. T., van der Schouw Y. T., Herber-Gast G. C., Maas A. H. More vasomotor symptoms in menopause among women with a history of hypertensive pregnancy diseases compared with women with normotensive pregnancies // Menopause, 2013. — № 20 (10). — P. 1006–1011.

Franklin S. S., Thijs L., Hansen T. W., O’Brien E., Staessen J. A. White-coat hypertension: new insights from recent studies // Hyper-tension, 2013. — № 62. — P. 982–987.

Beale A. L., Meyer P., Marwick T. H. et al. Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction // Circulation, 2018. — № 138 (2). — P. 198–205.

Williams B., Mancia G., Spiering W. et al. 2018 ESC/ESH guidelines for the management of arterial hypertension // Eur Heart J, 2018. — № 39. — P. 3021–3104.

Van den Hurk K., de Kort W LAM, Deinum J., Atsma F. Higher outdoor temperatures are progressively associated with lower blood pressure: a longitudinal study in 100,000 healthy individuals // J Am Soc Hypertens, 2015. — № 9 (7). — P. 536–543.

Verschuren W. M., Boerma G. J., Kromhout D. Total and HDL cholesterol in The Netherlands: 1987–1992. Levels and changes over time in relation to age, gender and educational level // Int J Epidemiol, 1994. — № 23 (5). — P. 948–956.

National Institute for Health and Care Excellence. Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease // National Clinical Guideline Centre, 2014. URL: www.nice.org.uk/guidance/cg181/evidence/lipid-modification-update-appendices-pdf-243786638(accessed 4th August 2020).

Cholesterol treatment trialists, Fulcher J., O’Connell R., Voysey M., Emberson J., Blackwell L. et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomized trials // Lancet, 2015. — № 385 (9976). — P. 1397–1405.

Thompson P. D., Panza G., Zaleski A. et al. Statin-associated side effects // J Am Coll Cardiol, 2016. — № 67 (20). — P. 2395–2410.

Vonbank A., Agewall S., Kjeldsen K. P. et al. Comprehensive efforts to increase adherence to statin therapy // Eur Heart J, 2017. — № 38. — P. 2473–2477.

Rosano G. M., Lewis B., Agewall S. et al. Gender differences in the effects of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC // Eur Heart J, 2015. — № 36 (40). — P. 2677–2680.

Qu H., Guo M., Chai H. et al. Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials // J Am Heart Assoc, 2018. — № 7. — e009835.

Nielsen S. F., Nordestgaard B. G. Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study // Eur Heart J, 2016. — № 37 (11). — P. 908–916.

Brouwers JRBJ, Roeters van Lennep JE, Maas AHEM. Rode gist rijst als cholesterolverlager? Een waarschuwing is op zijn plaats // Ned Tijdschr Geneeskd, 2016. — № 160. — D99. (Red yeast rice as cholesterol lowering product? A warning is in order.)

Trimarco B., Benvenuti C., Rozza F. et al. Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet // Med J Nutrition Metab, 2011. — № 4 (2). — P. 133–139.

Kautzky-Willer A., Handisurya A. Metabolic diseases and associated complications: sex and gender matter! // Eur J Clin Invest, 2009. — № 39 (8). — P. 631–648.

Chow C. K., Islam S., Bautista L. et al. Parental history and myocardial infarction risk across the world: the INTERHEART study // J Am Coll Cardiol, 2011. — № 57 (5). — P. 619–627.

Mulders T. A., Taraboanta C., Franken L. C. et al. Coronary artery calcification score as tool for risk assessment among families with premature coronary artery disease // Atherosclerosis, 2016. — № 245. — P. 155–160.

Miller V. N. M., Duckles S. P. Vascular actions of estrogens: functional implications // Pharmacol Rev, 2008. — № 60 (2). — P. 210–241.

Muka T., Oliver-Williams C., Kunutsor S. et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis // JAMA Cardiol, 2016. — № 1 (7). — P. 767–776.

Rees M., Angioli R., Coleman R. L., Glasspool R., Plotti F., Simoncini T. et al. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis // Maturitas, 2020. — № 134. — P. 56–61.

Thurston R. C. Vasomotor symptoms: natural history, physiology, and links with cardiovascular health // Climacteric, 2018. — № 21 (2). — P. 96–100.

Thurston R. C., Karvonen-Gutierrez C. A., Derby C. A. et al. Menopause versus chronologic aging: their roles in women’s health // Menopause, 2018. — № 25 (8). — P. 849–854.

Vongpatanasin W. Autonomic regulation of blood pressure in menopause // Semin Reprod Med, 2009. — № 27 (4). — P. 338–345.

Shufelt C. L., Bairey Merz C. N. Contraceptive hormone use and cardiovascular disease // J Am Coll Cardiol, 2009. — № 53 (3). — P. 221–231.

Bassuk S. S., Manson J. E. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes // Annals of Epidemiology, 2015. — № 25 (3). — P. 193–200.

Maas A. H., Euler Mv., Bongers M. Y. et al. Practice points in gynecardiology: abnormal uterine bleeding in premenopausal women taking oral anticoagulant or antiplatelet therapy // Maturitas, 2015. — № 82 (4). — P. 355–359.